Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-10-29

FDA Approved: DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE — Original Application (Prasco Laboratories)

View source ↗

Summary

The FDA approved a fixed-dose combination tablet of dapagliflozin and metformin hydrochloride from Prasco Laboratories for adults with type 2 diabetes mellitus …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapagliflozin and metformin hydrochloride (dapagliflozin and metformin hydrochloride)

Snippet

ORIG AP for DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE)